CAPITAL FUND MANAGEMENT S.A. - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 169 filers reported holding GW PHARMACEUTICALS PLC in Q4 2016. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
CAPITAL FUND MANAGEMENT S.A. ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2020$394,000
-87.2%
4,500
-84.7%
0.01%
-75.0%
Q4 2019$3,067,000
+1084.2%
29,332
+1203.1%
0.02%
+1100.0%
Q3 2019$259,000
-65.0%
2,251
-47.7%
0.00%
-71.4%
Q2 2019$741,000
+51.5%
4,300
+48.3%
0.01%
+40.0%
Q1 2019$489,000
-52.2%
2,900
-72.4%
0.01%
-44.4%
Q4 2018$1,023,000
-84.1%
10,500
-71.9%
0.01%
-74.3%
Q3 2018$6,451,000
+152.2%
37,351
+103.8%
0.04%
+169.2%
Q2 2018$2,558,000
-63.4%
18,328
-65.4%
0.01%
-65.8%
Q4 2017$6,988,000
+192.0%
52,936
+124.5%
0.04%
+123.5%
Q3 2017$2,393,000
+816.9%
23,582
+807.0%
0.02%
+750.0%
Q2 2017$261,000
-23.0%
2,600
-7.1%
0.00%
-33.3%
Q1 2017$339,000
-98.2%
2,800
-98.3%
0.00%
-98.1%
Q4 2016$18,684,000
+274.0%
167,191
+344.2%
0.16%
+250.0%
Q3 2016$4,996,000
+1851.6%
37,641
+960.3%
0.05%
+2200.0%
Q1 2016$256,0003,5500.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q4 2016
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 390,000$45,010,0007.31%
Copernicus Capital Management, LLC 2,788$322,0005.02%
Integral Health Asset Management, LLC 72,500$8,367,0002.49%
Parkman Healthcare Partners LLC 81,573$9,414,0002.41%
AdvisorShares Investments LLC 66,317$7,654,0001.78%
Tri Locum Partners LP 40,159$4,635,0001.68%
ETF MANAGERS GROUP, LLC 621,361$71,711,0001.57%
Redmile Group, LLC 815,681$94,138,0001.14%
Redwood Investments, LLC 108,999$12,580,0001.07%
ROOSEVELT INVESTMENT GROUP LLC 127,885$14,759,0001.05%
View complete list of GW PHARMACEUTICALS PLC shareholders